- Home
- CMPS vs OSUR Comparison
CMPS vs OSUR Comparison
Compare CMPS & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- OSUR
- Stock Information
- Founded
- CMPS 2020
- OSUR 2000
- Country
- CMPS United Kingdom
- OSUR United States
- Employees
- CMPS N/A
- OSUR N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- OSUR Medical/Dental Instruments
- Sector
- CMPS Health Care
- OSUR Health Care
- Exchange
- CMPS Nasdaq
- OSUR Nasdaq
- Market Cap
- CMPS 246.5M
- OSUR 223.0M
- IPO Year
- CMPS 2020
- OSUR 1986
- Fundamental
- Price
- CMPS $3.91
- OSUR $2.67
- Analyst Decision
- CMPS Strong Buy
- OSUR Hold
- Analyst Count
- CMPS 6
- OSUR 2
- Target Price
- CMPS $20.20
- OSUR $5.50
- AVG Volume (30 Days)
- CMPS 862.1K
- OSUR 458.5K
- Earning Date
- CMPS 05-08-2025
- OSUR 05-07-2025
- Dividend Yield
- CMPS N/A
- OSUR N/A
- EPS Growth
- CMPS N/A
- OSUR N/A
- EPS
- CMPS N/A
- OSUR N/A
- Revenue
- CMPS N/A
- OSUR $161,626,000.00
- Revenue This Year
- CMPS N/A
- OSUR N/A
- Revenue Next Year
- CMPS N/A
- OSUR $7.55
- P/E Ratio
- CMPS N/A
- OSUR N/A
- Revenue Growth
- CMPS N/A
- OSUR N/A
- 52 Week Low
- CMPS $2.49
- OSUR $2.69
- 52 Week High
- CMPS $9.63
- OSUR $5.59
- Technical
- Relative Strength Index (RSI)
- CMPS 58.19
- OSUR 37.33
- Support Level
- CMPS $3.62
- OSUR $2.42
- Resistance Level
- CMPS $4.00
- OSUR $3.09
- Average True Range (ATR)
- CMPS 0.28
- OSUR 0.11
- MACD
- CMPS -0.00
- OSUR -0.02
- Stochastic Oscillator
- CMPS 48.23
- OSUR 36.76
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.